Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aesthetic Medicine

1,358.943
+66.5335.15%
Number of Gainers:10
Number of Losers:1
Number of Flat:2
PE:- -
High:1,366.519
Open:1,292.595
Low:1,292.595
Close:1,292.410
Volume:90.12M
Turnover:2.32B
Market Cap:219.26B
Float Cap:164.87B

Loading ...

Hong Kong Stock Buyback Summary | November 6

Stock News
·
Nov 06

Fosun Pharma Approves First Grants Under 2025 A Share Option, H Share RSU Schemes

MT Newswires Live
·
Nov 05

Angelalign Technology Integrates Dexis, Shining 3D, and Panda Scanner into iOrtho Platform

Reuters
·
Nov 05

FOSUN PHARMA (02196) Grants 4.5351 Million A-Share Options in Total

Stock News
·
Nov 04

AH Premium Rate and Deviation Rankings as of November 4

Stock News
·
Nov 04

Exclusive Novartis Ophthalmology Deal Might Change The Case For Investing In China Medical System Holdings (SEHK:867)

Simply Wall St.
·
Nov 04

Fosun Pharma Releases Q3 2025 Report: Innovation Deliveries Continue, Novel Drug Revenue Exceeds RMB 6.7 Billion in First Three Quarters

Deep News
·
Nov 03

HAOHAI BIOTEC (06826) Repurchased 10,000 Shares for HK$276,800 on November 3

Stock News
·
Nov 03

AH Premium Rate and Deviation Rankings as of November 3

Stock News
·
Nov 03

Insiders Of 3SBio Retain CN¥7.6m Of Investment Selling At Higher Prices

Simply Wall St.
·
Nov 03

Hong Kong Stock Buyback Summary | November 3

Stock News
·
Nov 03

Angelalign Technology Inc. Files Director List with HKEX

Reuters
·
Nov 02

Are China Medical System Holdings Limited's (HKG:867) Mixed Financials Driving The Negative Sentiment?

Simply Wall St.
·
Nov 01

Shanghai Haohai Biological Technology's (HKG:6826) Problems Go Beyond Weak Profit

Simply Wall St.
·
Nov 01

Princes Group makes subdued start to trading in London IPO

Reuters
·
Oct 31

Fosun Pharma Plans to Spin Off Vaccine Subsidiary for Hong Kong IPO

Deep News
·
Oct 31

AH Premium Rate Statistics as of October 31

Stock News
·
Oct 31

FOSUN PHARMA (02196) Rises Nearly 4% Intraday as Q1-Q3 Net Profit Grows 25.5% YoY, Continues Advancing Innovative Product Launches

Stock News
·
Oct 31

HK Movers|3SBIO Rises 8% in Early Trading as Pfizer Initiates Two Global Phase III Trials for SSGJ-707

Stock News
·
Oct 31

HK Stock Buyback Summary | October 31

Stock News
·
Oct 31